HEALTHIX INC

SHIN-NY GRANT/HCRA/MEDICAID PROGRAMPROGRAM DESCRIPTIONHEALTHIX WORKS WITH OUR PARTICIPANTS TO INTEGRATE THEM INTO THE HIE AND TO WORK WITH THEM TO DESIGN AND DEVELOP PRODUCTS AND SERVICES THAT HELP THEM TO IMPROVE CARE THROUGH BETTER CARE COORDINATION. IN 2023 WE USED THE FUNDING FROM SHIN-NY/HCRA/MEDICAID TO SUPPORT CUSTOMER ENGAGEMENT, COMPLIANCE, RELATIONSHIP MANAGEMENT, PROJECT MANAGEMENT, OPERATIONS, DEVELOPMENT, DATA QUALITY IMPROVEMENT, ENGINEERING, QUALITY ASSURANCE AND SUPPORT. OUR CUSTOMER ENGAGEMENT TEAM RECRUITED NEW PARTICIPANTS, ENSURED COMPLIANCE WITH STATE PRIVACY & SECURITY POLICIES AND PREPARED STATEMENTS OF WORK TO HAND OFF TO THE PROJECT MANAGEMENT, CUSTOMER EXPERIENCE AND DEVELOPMENT & ENGINEERING TEAMS.CUSTOMER ENGAGEMENT TEAM WAS COMPRISED OF TWO CUSTOMER ENGAGEMENT MANAGERS REPORTING INTO THE VICE PRESIDENT OF CUSTOMER EXPERIENCE. THE COMPLIANCE DEPARTMENT IS COMPRISED OF AN ASSISTANT VICE PRESIDENT OF COMPLIANCE AND PRIVACY OFFICER AND FIVE COMPLIANCE STAFF. THE PROJECT MANAGEMENT DEPARTMENT IS COMPRISED OF A VICE PRESIDENT, FIVE PROJECT MANAGERS, A PROJECT MANAGEMENT TEAM LEAD, A QUALITY ASSURANCE LEAD, TWO QUALITY ASSURANCE ENGINEERS, A MANAGER OF OPERATIONS WITH TWO ANALYSTS AND A TRAINING SPECIALIST. THE CUSTOMER EXPERIENCE TEAM IS COMPRISED OF A VICE PRESIDENT, A DIRECTOR OF RELATIONSHIP MANAGEMENT WITH EIGHT RELATIONSHIP MANAGERS, A COMMUNICATIONS MANAGER, AN ASSISTANT VICE PRESIDENT OF CUSTOMER SUPPORT WITH SEVEN CUSTOMER SUPPORT STAFF. THE DEVELOPMENT OPERATIONS TEAM IS LED BY A SENIOR DIRECTOR AND COMPRISED OF A DIRECTOR OF DATA STRATEGY AND EIGHT DATA ANALYSTS, A DIRECTOR OF DEVELOPMENT WITH FIVE INTEGRATION ENGINEERS AND A SYSTEMS ENGINEERING TEAM COMPRISED OF EIGHT NETWORK ENGINEERS. THE INFORMATION SECURITY GROUP REPORTS INTO THE CIO AND IS COMPRISED OF A CHIEF INFORMATION SECURITY OFFICER AND TWO INFORMATION SECURITY ANALYSTS. IN ADDITION, THE SHIN-NY GRANT/HCRA/MEDICAID PROGRAM FUNDING SUPPORTED OFFICE SPACE AND DATA CENTER OPERATIONS.ACCOMPLISHMENTSIN 2023 HEALTHIX COMPLETED 271 PROJECTS INCLUDING CUSTOMER PROJECTS, INTERNAL PROJECTS, VENDOR DEVELOPMENT PROJECTS, PRODUCT DEVELOPMENT PROJECTS, GRANTS PROJECTS AND PUBLIC HEALTH PROJECTS. THE CUSTOMER PROJECTS INCLUDED CONNECTING NEW PARTICIPANTS TO HEALTHIX AND PROVIDING THEM WITH STANDARD AND CUSTOM SERVICES. AT THE BEGINNING OF 2023, HEALTHIX LAUNCHED A NEW SERVICE TO SUPPORT PROVIDERS IN POPULATION HEALTH AND VALUE-BASED CARE. THE NEW SERVICE IS DESIGNED TO HELP PROVIDERS IDENTIFY AND FOLLOW UP WITH HIGH-RISK PATIENTS AND MEET QUALITY MEASURES AND ACHIEVE HIGHER INCENTIVE PAYMENTS. HEALTHIX HAS INVESTED IN THE DEVELOPMENT AND SUBSIDIZED THE LICENSE FEES IN ORDER TO ENHANCE ADOPTION. AS THE PRODUCT MATURES AND IS ABLE TO DEMONSTRATE VALUE, CUSTOMERS WILL BE ASKED TO PAY MARKET RATES FOR THE SERVICE AND PROVIDE A NEW REVENUE STREAM FOR HEALTHIX.DURING THE YEAR ENDED DECEMBER 31, 2023, THE COMPANY RECORDED $19,079,214 IN REVENUE IN CONNECTION WITH THIS PROGRAM.NYC DOHMHIN 2023 HEALTHIX CONTINUED A TWO-YEAR CONTRACT WITH THE NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE (DOHMH) TO DEVELOP NEW FUNCTIONALITY AND INFRASTRUCTURE IMPROVEMENTS TO ENHANCE THE DEPARTMENT'S ABILITY TO PERFORM DISEASE SURVEILLANCE AND EPIDEMIOLOGY. THE YEAR 2 CONTRACT WAS EXECUTED IN JUNE OF 2023.HYPERTENSION PROGRAM HRI HEALTH RESEARCHTHE HTN PROJECT CONSISTS OF PARTNERING WITH NYS DEPARTMENT OF HEALTH TO ANALYZE HEALTHIX'S 2021 DATASET TO GET A CLOSER LOOK INTO THE CHRONIC DISEASE OF HYPERTENSION. THE PROJECT PROVIDED AN IN-DEPTH OPPORTUNITY FOR HEALTHIX TO CLINICALLY EVALUATE AND UNDERSTAND THE ISSUES PERTAINING TO HYPERTENSION WITHIN OUR PATIENT POPULATION. WE REVIEWED THE FOLLOWING CRITERIA'S, HYPERTENSION PREVALENCE, CONTROLLED AND UNDIAGNOSED HYPERTENSION MEASURES. WE STRATIFIED THE DATA BY AGE, GENDER, ZIP CODE, COUNTY, RACE AND ETHNICITY IN DETAIL. WE ANALYZED PRIMARY VS SECONDARY HYPERTENSION MEASURES FOR HEALTHIX'S CATCHMENT AREA WITHIN NYC AND LONG ISLAND FOR PATIENTS 18-85 OF AGE. WE ALSO ANALYZED PATIENTS OUTSIDE OF HEALTHIX CATCHMENT AREA AND THE NON-HYPERTENSION PATIENTS WITHIN THE SAME STUDY YEAR. HEALTHIX REVIEWED LOCAL AND STANDARD DIAGNOSIS DATA AND STANDARDIZED PATIENTS THAT ARE SOLELY HYPERTENSIVE VS PATIENTS WITH ANOTHER UNDERLYING DISEASE-CAUSING HYPERTENSION. OUR FINDINGS WITHIN OUR DATASET INCLUDE THE FOLLOWING:- MAJORITY LOWEST ZIPS WERE IN THE BRONX- MAJORITY HIGHEST ZIPS FOR HTN PATIENTS WITHIN OUR DATASET ARE IN QUEENS AND BROOKLYN- 10.2MILLION DISTINCT INDIVIDUALS ARE NON-HYPERTENSION PATIENTS WITHIN 2021 - 1.4MILLION DISTINCT INDIVIDUALS ARE HYPERTENSION PATIENTS WITHIN 2021- MAJORITY OF PATIENTS WITH HTN ARE ADULTS AGES 50+- HTN PATIENTS AGES 18-85 PREVALENCE RATE = 93.4% - HTN CONTROLLED PATIENTS AGES 18-85 CONTROL RATE = 61.1%, AROUND 2/3 OF THE POPULATION IS TAKING CONTROL MEASURETHE PROJECT OUTCOME WAS A SUCCESS AND HEALTHIX WILL BE LAUNCHING A LIVE HYPERTENSION CLINICAL DASHBOARD BY END OF 2024 TO TRACK PATIENTS' HEALTH OUTCOME WITHIN THIS TROUBLING DISEASE. PUBLIC HEALTH DATA LAKEGOALTHE GOAL OF THIS PROJECT WAS TO SEND DATA TO A PUBLIC HEALTH DATA LAKE FOR USE BY THE NYS DOHDESCRIPTIONAS PART OF THE SHIN-NY, HEALTHIX WAS RESPONSIBLE FOR SUBMISSION OF ADT (PATIENT ADMITS AND DISCHARGES) AND ORU(LAB AND RADIOLOGY RESULTS) FROM OUR PARTICIPANTS INTO THE SHIN-NY DATA LAKE COVID DATA FOR PATIENTS WITHIN OUR CATCHMENT AREA. THIS WAS ACCOMPLISHED THROUGH CONVERTING THE ADT AND ORU MESSAGES TO FHIR AND AN AUTOMATED PUSH OF THE FHIR MESSAGES TO THE DATA LAKE.DURING THE YEAR ENDED DECEMBER 31, 2023, THE COMPANY RECORDED $285,000 IN REVENUE IN CONNECTION WITH THIS PROGRAM.CIVITAS/GRAVITY PROJECTGOALTO STANDARDIZE THE FORMAT AND DELIVERY OF HEALTH-RELATED SOCIAL NEEDS (HRSN) FOR DELIVERY INTO THE SHIN-NY DATA LAKE.DESCRIPTIONHEALTHIX WAS A PARTICIPANT IN THE CONVERSATIONS AND DESIGN DECISIONS TO ALIGN ALL THE QUALIFIED ENTITIES (PARTICIPANTS IN THE SHIN-NY) ON THE FORMAT AND DATA TO BE INCLUDED IN THE SUBMISSION OF HRSN DATA INTO THE SHIN-NY DATA LAKE IN ANTICIPATION OF THE 1115 WAIVER.DURING THE YEAR ENDED DECEMBER 31, 2023, THE COMPANY RECORDED $50,000 IN REVENUE IN CONNECTION WITH THIS PROGRAM.COVID REGISTRYGOALTHE GOAL OF THIS PROJECT WAS TO AGGREGATE COVID TEST RESULTS AT THE STATEWIDE LEVEL TO PROVIDE A COMPREHENSIVE VIEW OF ALL COVID PATIENTS THROUGHOUT NY STATE.DESCRIPTIONAS PART OF THE SHIN-NY, HEALTHIX WAS RESPONSIBLE FOR SUBMISSION OF CONTINUITY OF CARE DOCUMENTS (CCD/CCDAS) TO THE SHIN-NY COVID DATA REPOSITORY FOR PATIENTS WITHIN OUR CATCHMENT AREA. THIS WAS ACCOMPLISHED THROUGH AN AUTOMATED PUSH OF A CCD/CCDA FOR PATIENT WHO HAD A POSITIVE COVID TEST RESULT.DURING THE YEAR ENDED DECEMBER 31, 2023, THE COMPANY RECORDED $53,073 IN REVENUE IN CONNECTION WITH THIS PROGRAM.AMBULATORY SURGERY CENTERS I&IGOALTO CONNECT AMBULATORY SURGERY CENTERS TO HEALTHIX TO CAPTURE PROCEDURES FOR OUTPATIENT SURGERIES.DESCRIPTIONHEALTHIX ENGAGED 3 MULTI-SITE AMBULATORY SURGERY CENTERS TO INTEGRATE INTO THE SHIN-NY AND PROVIDE INFORMATION ON THE OUTPATIENT PROCEDURES THAT ARE PERFORMED WITHIN THEM.DURING THE YEAR ENDED DECEMBER 31, 2023, THE COMPANY RECORDED $64,000 IN REVENUE IN CONNECTION WITH THIS PROGRAM.CLINITHINK ASTRA ZENECA GOALPROVIDE CONCISE DE-IDENTIFIED DATA ON A SPECIFIED GROUP OF PATIENTS TO ASCERTAIN IF THERE WAS ENOUGH EVIDENCE TO PROMOTE A CLINICAL TRIAL.DESCRIPTIONPROVIDE STRUCTURED DATA AND UNSTRUCTURED DATA TO CLINITHINK INTO THEIR APPLICATION THAT RESIDES IN OUR DATA CENTER. WORK WITH THE CLINITHINK STAFF TO DETERMINE IF THERE IS ENOUGH EVIDENCE TO ADVANCE THE IDEA OF A CLINICAL TRIAL.DURING THE YEAR ENDED DECEMBER 31, 2023, THE COMPANY RECORDED $32,000 IN REVENUE IN CONNECTION WITH THIS PROGRAM.